Co-founder of 4DMT; CEO and director since the company's inception in 2013 and President since January 2026. Former Executive Chairman until August 2020. Adjunct Professor of Bioengineering and Molecular & Cellular Biology at U.C. Berkeley and co-founder of the U.C. Berkeley Life Sciences Entrepreneurship Center. Previously co-founder and Executive Chairman of Ignite Immunotherapy and held senior development roles at Onyx Pharmaceuticals and Celgene.